Despite Evidence of Benefit, Developing Countries Often Lack Routine Lung Cancer Screening Practices
Ricardo Sales dos Santos, MD, PhDExpert panel to discuss challenges and opportunities for increasing LDCT screening in Latin America during LALCA 2023. Read more
Presidential Symposium Features Best of Abstract Submissions
Luis E. Raez, MD+more
Highlighted studies explore the association of TP53 mutations with inferior prognosis in NSCLC patients of African ancestry, the possibilities for next-generation sequencing to guide therapy, and the use of a 12-gene expression panel to predict treatment benefit. Read more
Passing of The Baton—On the Death of Patient Research Advocates
Angus Pratt, MBAPatient Perspective: We honor those we’ve lost by continuing their advocacy work, patient advocate Angus Pratt says. Read more
New Screening Approach Needed to Detect Lung Cancer in Patients who Never Smoked
Erin JungmeyerDuring ACLC 2022, Dr. Gee-Chen Chang made the case for moving beyond smoking history to identify at-risk patients and shared an alternative risk predication model that compared favorably against NLST and NELSON. Read more
Palliative Care Benefits Vary Depending on Providers, Timing
Erin JungmeyerIn the first of a series of articles on supportive care in lung cancer, Dr. David Hui outlines the needs and reviews evidence-based best practices. Read more
Learn how new guidance from the UK’s National Institutes for Health Care Excellence addresses an unmet clinical need for patients with EGFR+ NSCLC with exon 20 insertion and stay up to date on the latest meeting news from IASLC. Read more
Targeted Therapies Expanding for MET Dysregulation in NSCLC
Erin JungmeyerDuring ACLC 2022, Dr. Noemi Reguart reviewed the data for MET-targeting TKIs and monoclonal antibodies for patients with METex14 skipping mutations, MET amplification, and MET overexpression. Read more
IASLC selects multidisciplinary slate of physicians to chair WCLC 2024 and announces last call for abstracts for TTLC 2023. Read more
Go2 Foundation coordinates educational events across the United States to improve lung cancer awareness; abstract submissions open for 2023 European Lung Cancer Congress; and registration begins for inaugural Texas Lung Cancer Conference. Read more
Growing Body of Evidence Highlights Potential Applications for Liquid Biopsy in Clinical Practice
Erin JungmeyerDuring a lecture at NACLC 22, Dr. Christian Rolfo illustrated how ctDNA could be used to monitor progression and inform treatment decisions. Read more